Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Invert Neurosci
2016 Dec 01;164:10. doi: 10.1007/s10158-016-0193-4.
Show Gene links
Show Anatomy links
The cholinomimetic morantel as an open channel blocker of the Ascaris suum ACR-16 nAChR.
Abongwa M
,
Baber KE
,
Martin RJ
,
Robertson AP
.
???displayArticle.abstract???
Nematode parasite infections pose a significant threat in human and veterinary medicine. At least a third of the world's population is at risk from nematode parasite infections. These infections not only cause health problems, but also cause loss of livestock production and hence, economic losses. Anthelmintic drugs are the mainstay by which control of nematode parasite infections is achieved. Many of the currently available anthelmintics act on nicotinic acetylcholine receptors (nAChRs). However, the detailed mode of action (MOA) of these anthelmintics is not clearly understood. Elucidation of the MOA of anthelmintics is highly desirable; an in-depth knowledge of the MOA will better inform on mechanisms of resistance development and on ways to slow down or overcome resistance. The cholinomimetic anthelmintic, morantel, has a complex MOA involving the activation and block of levamisole-sensitive single nAChR channels (L-type nAChR or L-nAChR). More recently, morantel has been demonstrated to activate Haemonchus contortus and Parascaris equorum ACR-26/ACR-27 nAChRs expressed in Xenopus laevis oocytes. Previous studies in our laboratory, however, have shown morantel does not activate the nicotine-sensitive nAChR (N-type nAChR or N-nAChR), Ascaris suum ACR-16 (Asu-ACR-16). In this study, we used two-electrode voltage-clamp (TEVC) electrophysiology to investigate the inhibitory effects of morantel, on expressed Asu-ACR-16 nAChRs in X. laevis oocytes. Our results show that morantel acts as a non-competitive antagonist on Asu-ACR-16. This non-competitive antagonism by morantel was further demonstrated to be voltage-sensitive. We conclude based on our findings that morantel is a non-competitive voltage-sensitive open channel blocker of Asu-ACR-16.
Abongwa,
Curiouser and Curiouser: The Macrocyclic Lactone, Abamectin, Is also a Potent Inhibitor of Pyrantel/Tribendimidine Nicotinic Acetylcholine Receptors of Gastro-Intestinal Worms.
2016, Pubmed,
Xenbase
Abongwa,
Curiouser and Curiouser: The Macrocyclic Lactone, Abamectin, Is also a Potent Inhibitor of Pyrantel/Tribendimidine Nicotinic Acetylcholine Receptors of Gastro-Intestinal Worms.
2016,
Pubmed
,
Xenbase
Abongwa,
Pharmacological profile of Ascaris suum ACR-16, a new homomeric nicotinic acetylcholine receptor widely distributed in Ascaris tissues.
2016,
Pubmed
,
Xenbase
Ballivet,
Nicotinic acetylcholine receptors in the nematode Caenorhabditis elegans.
1996,
Pubmed
,
Xenbase
Bethony,
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm.
2006,
Pubmed
Brooker,
Global epidemiology, ecology and control of soil-transmitted helminth infections.
2006,
Pubmed
Buxton,
Investigation of acetylcholine receptor diversity in a nematode parasite leads to characterization of tribendimidine- and derquantel-sensitive nAChRs.
2014,
Pubmed
,
Xenbase
Courtot,
Functional Characterization of a Novel Class of Morantel-Sensitive Acetylcholine Receptors in Nematodes.
2015,
Pubmed
,
Xenbase
de Silva,
Soil-transmitted helminth infections: updating the global picture.
2003,
Pubmed
Evans,
Activation and cooperative multi-ion block of single nicotinic-acetylcholine channel currents of Ascaris muscle by the tetrahydropyrimidine anthelmintic, morantel.
1996,
Pubmed
Holden-Dye,
Anthelmintic drugs.
2007,
Pubmed
Holden-Dye,
Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans.
2014,
Pubmed
Hotez,
Helminth infections: the great neglected tropical diseases.
2008,
Pubmed
Karlin,
Emerging structure of the nicotinic acetylcholine receptors.
2002,
Pubmed
Lustigman,
Potential involvement of Brugia malayi cysteine proteases in the maintenance of the endosymbiotic relationship with Wolbachia.
2014,
Pubmed
Martin,
Electrophysiology of Ascaris muscle and anti-nematodal drug action.
1996,
Pubmed
Martin,
Modes of action of anthelmintic drugs.
1997,
Pubmed
Martin,
Anthelmintics and ion-channels: after a puncture, use a patch.
1998,
Pubmed
Martin,
Target sites of anthelmintics.
1997,
Pubmed
Martin,
Oxantel is an N-type (methyridine and nicotine) agonist not an L-type (levamisole and pyrantel) agonist: classification of cholinergic anthelmintics in Ascaris.
2004,
Pubmed
Morel,
Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis.
2014,
Pubmed
Qian,
Pharmacology of N-, L-, and B-subtypes of nematode nAChR resolved at the single-channel level in Ascaris suum.
2006,
Pubmed
Rayes,
Activation of single nicotinic receptor channels from Caenorhabditis elegans muscle.
2007,
Pubmed
Raymond,
Anthelmintic actions on homomer-forming nicotinic acetylcholine receptor subunits: chicken alpha7 and ACR-16 from the nematode Caenorhabditis elegans.
2000,
Pubmed
,
Xenbase
Robertson,
Electrophysiological recording from parasitic nematode muscle.
2008,
Pubmed
Touroutine,
acr-16 encodes an essential subunit of the levamisole-resistant nicotinic receptor at the Caenorhabditis elegans neuromuscular junction.
2005,
Pubmed
Wolstenholme,
Ion channels and receptor as targets for the control of parasitic nematodes.
2011,
Pubmed
Zheng,
The Ascaris suum nicotinic receptor, ACR-16, as a drug target: Four novel negative allosteric modulators from virtual screening.
2016,
Pubmed
,
Xenbase
Zouridakis,
Recent advances in understanding the structure of nicotinic acetylcholine receptors.
2009,
Pubmed
